Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Assessment of Functionality of Smart Eye Camera: A Smartphone-attached Slit-Lamp Microscope and Fundus Camera.
Author Affiliations & Notes
  • Eisuke Shimizu
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
    OUI Inc., Japan
  • Yoko Ogawa
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
  • Shinri Sato
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
    Yokohama Keiai Eye Clinic, Japan
  • Ryota Yokoiwa
    OUI Inc., Japan
  • Shintaro Nakayama
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
    OUI Inc., Japan
  • Rohan Jeetendra Khemlani
    OUI Inc., Japan
    Yokohama Keiai Eye Clinic, Japan
  • Hiroki Nishimura
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
    OUI Inc., Japan
  • Masatoshi Hirayama
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
  • Kazuo Tsubota
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
    tsubota lab, Japan
  • Yasunori Sato
    Preventive Medicine and Public Health, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
  • Shigeto Shimmura
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
    Clinical Regenerative Medicine, Fujita Ika Daigaku, Toyoake, Aichi, Japan
  • Kazuno Negishi
    Ophthalmology, Keio Gijuku Daigaku Igakubu Daigakuin Igaku Kenkyuka, Shinjuku-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Eisuke Shimizu OUI Inc./16/964822, Code P (Patent); Yoko Ogawa None; Shinri Sato None; Ryota Yokoiwa None; Shintaro Nakayama None; Rohan Khemlani OUI Inc., Code E (Employment); Hiroki Nishimura OUI Inc., Code E (Employment); Masatoshi Hirayama None; Kazuo Tsubota None; Yasunori Sato None; Shigeto Shimmura None; Kazuno Negishi None
  • Footnotes
    Support  Japan Agency for Medical Research and Development
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3390. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eisuke Shimizu, Yoko Ogawa, Shinri Sato, Ryota Yokoiwa, Shintaro Nakayama, Rohan Jeetendra Khemlani, Hiroki Nishimura, Masatoshi Hirayama, Kazuo Tsubota, Yasunori Sato, Shigeto Shimmura, Kazuno Negishi; Assessment of Functionality of Smart Eye Camera: A Smartphone-attached Slit-Lamp Microscope and Fundus Camera.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3390.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : This study aims to assess the functionality of the Smart Eye Camera(SEC), a device that integrates the functionality of a slit-lamp microscope(SLM) and a fundus camera(FC) using smartphone. The evaluation will focus on its application in diagnostics, in terms of its safety for eyes and its diagnosis compared to standard ophthalmic equipments.

Methods : We prospectively analyzed 40 cases involving 80 eyes from a gender- and age-matched cohort(approved by Certified review board of Keio #20180002). Our objective was to compare clinical parameters using the SEC against those obtained with conventional SLMs and FCs. We conducted a safety evaluation that included assessments before and after using SEC in the anterior segment of the eyes, encompassing (1)corneal fluorescein scores(CFS), (2)conjunctival staining scores(LG), (3)central corneal thickness(CCT), and others. Additionally, we evaluated the fundus parameters as (4)ganglion cell complex value(GCC), (5)critical fusion frequency(CFF), macular edema(ME), retinal hemorrhage, among others. Diagnostic function were comparing using SEC and conventional devices. We compared (I)tear film break-up time(TFBUT), (II)meibomian gland dysfunction(MGD), (III)hyperemia as anterior segment, and (IV)cup-to-disc(CD) ratio, (V)Keith-Wagner(KW) and (VI)Scheie's(S) classifications, as posterior segmant.

Results : One participant was excluded due to non-adherence to the study protocol. Safety evaluations as assessments of CFS, LG, CCT, GCC, and CFF, the results indicated no significant adverse changes in these parameters. Additionally, there were no other adverse events such as ME, hemorrhage, elevation of intraocular pressure, or decreased visual acuity, suggesting the safety of the SEC. In the diagnostic evaluation of TFBUT, MGD, hyperemia, CD ratio, the KW&S classification, all parameters showed no statistically significant differences (P>0.05). Furthermore, strong correlation(r=0.73-0.99) and kappa values(κ=0.84-1.00) were observed across all metrics, affirming the SEC's valid function in diagnosis.

Conclusions : SEC exhibits comparable functionality to both conventional SLMs and FCs. Additionally, its utilization of a smartphone's light source significantly enhances the potential for broadening the scope of remote ophthalmology, thereby enabling eye care in a variety of settings.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×